SRN Advisors’s Merck MRK Stock Holding History

SRN Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$659K	Buy	8,325 +326	+4%	+$25.9K	0.6%	80
2025 Q1	$718K	Sell	7,999 -218	-3%	-$20.4K	0.81%	65
2024 Q4	$817K	Buy	+8,217	New	+$847K	0.73%	72
2021 Q4	–	Sell	-6,569	Closed	-$493K	–	123
2021 Q3	$493K	Sell	6,569 -11,179	-63%	-$850K	0.23%	81
2021 Q2	$1.38M	Sell	17,748 -2,739	-13%	-$204K	0.47%	74
2021 Q1	$1.51M	Sell	20,487 -4,226	-17%	-$312K	0.54%	71
2020 Q4	$1.9M	Buy	+24,713	New	+$1.89M	0.93%	49

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SRN Advisors's MRK Position: Q2 2025 in Review

SRN Advisors increased its Merck (MRK) stake by 4.1% in Q2 2025, buying an estimated $25.9K and bringing the position to 8,325 shares worth $659K. The position accounts for 0.6% of the portfolio, ranked #80.

SRN Advisors first reported a position in MRK in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.9M in Q4 2020. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

SRN Advisors held 8,325 shares of Merck worth $659K as of Q2 2025.
SRN Advisors bought 326 Merck shares in Q2 2025, an estimated $25.9K.
Merck made up 0.6% of SRN Advisors's portfolio in Q2 2025, its #80 holding.
SRN Advisors first reported a position in Merck in Q4 2020 and has held it in 7 quarters since.
SRN Advisors's Merck position peaked at $1.9M in Q4 2020.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.